With their hands on the legal levers

It is wonderful news for the Scandinavian scientific community. At the end of May it stood clear that Lund will host to the European Spallation Source.

Will the industry follow the economic revival?

Welcome to the eleventh Biotech Forum + Scanlab Fair!

Elekta gets ok from China

The Swedish medtech comapny Elekta has received approval from the Chinese authority State Food and Drug Administration, SFDA, to sell its linear accelerator in China.

Hey Johannes Hedman...

... graduate of SKL and LTH, who has improved a method of forensic analysis

A crash course in IP strategy

"Publish, publish, publish!" Sound familiar? So to meet the researcher's wishes, do you scribble a patent application with lipstick on a napkin and send it in? ...

New member to Active board

The Election Committee of Active Biotech proposes a very experienced financial sector executive to join the company board. Five existing members are also to be ...

180 miljoner till nanoforskning

En stor satsning från det europeiska programmet Euro Nano Med ska finansiera två svenska nanoforskningsprojekt. Chalmers tekniska högskola, Linköpings universit...

Age essential when testing drugs

Anders Rane has been arguing that genes and age are both important factors in understanding how medicines affect individuals. Only last year, the EU established...

Swedish top scientists to EMBO

Two Swedish top scientists will have a really good chance to influence European life science research from now on. One is from the Karolinska Institutet, and on...

EUR 2 million for peanut allergies

ALK Abelló has signed an agreement to invest EUR 2 million in the French biotechnology company DBV Technologies.

Athera signs production partnership

The companys novel cardiovascular product will be manufactured in Germany.

Acadia drug awarded

Acadia Pharmaceutical has got an award for a new treatment against Parkinson's disease.

9 steps to perfect partnering

Rigorous planning and a focus on your business plan is essential for successful partnering, accoring to Camilla Huse Bondeson at Conlega. Follow her 9 steps to ...

Collaboration brings next generation drugs

Wyeth and Santaris Pharma announce a new alliance to develop RNA-based medicines.

Test if you carry the fat virus

In a soon future there may be a quick and simple test that could show if you are infected with Ad-36, a human adenovirus that can make you over-weight.

Fat cells' reaction differs with body weight

The fat cells of overweight people may react differently to dietary changes than in their lean peers, according to a pioneering study from the Dutch organizatio...

Showroom for free

The latest equipment with trained staff. Sci Life Lab in Stockholm want to offer top conditions at the new imaging laboratory. But some vendors are skeptical to...

Harmony prevents dementia

People who are active, outgoing and relaxed may be less likely to develop dementia, according to a new study from Karolinska Institutet.

We are poor lobbyists

I doubt there has ever been a really well thought out Scandinavian campaign with intentions to really change attitudes among both the public and politicians.

From planning stage to handshake

"Partnering is an effective tool to get in touch with the decision makers high up in an organization's administration," says Camilla Huse Bondeson at Conlega. A...

Pfizers medicinske chef: ”Hela andan på företaget är oerhört patientfokuserad”

Som anestesiläkare i Lund hjälpte Jonas Ålebring en patient i taget. Som Pfizers nye medicinske chef har han möjligheten att hjälpa tusentals patienter samtidig...

How to get the most out of the fair

AxFlow ställer ut på Livsmedelsproduktion 17-18 April 2013, MalmöMässan

Den 17 och 18 april 2013 har det på nytt blivit dags för Nordens största mässa inom Livsmedelsproduktion. Besök vår monter F:09 och träffa våra säljare.

Vill maxa nyttan av forskningsinfrastrukturen

För att dra maximal nytta av investeringar i forskningsinfrastruktur ska Vetenskapsrådet och Vinnova samordna arbetet kring jättesatsningarna ESS och MAX IV.